The value of innovative ICT guided disease management combined with telemonitoring in outpatient clinics for chronic heart failure patients.

niversity Medical Center Groningen (UMCG), department of cardiology0 个研究点目标入组 450 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

•Patients are eligible when they are admitted to the IC/CCU or cardiology ward for heart failure, NYHA class III-IV, have evidence for structural underlying heart disease, are intravenously treated with diuretics during their hospitalisation, have a documented ejection fraction less or equal than 40% in the previous 3 months, are at least 18 years old, male or female and are able to understand content of and willing to provide informed consent.

•Patients will be excluded from the study when they have a history of myocardial infarction in the previous 1 month, have a life expectation less then 1 year, have a history of valve replacement or surgery within the previous 6 months, have undergone cardiac invasive intervention within the last 6 months or planned to have such a procedure in the following 3 months, are evaluated for heart transplantation prior or during the study, are inable to fill out questionnaires, are inable to use telemedicine devices at home or participate at another clinical intervention trial.

发起方

niversity Medical Center Groningen (UMCG), department of cardiology